Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021
Enrollment ongoing in three Cellectis-sponsored Phase 1 dose-escalation clinical studies BALLI-01 in r/r B-ALL patients,…
Month: May 2021
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance
PRINCETON, N.J., May 06, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…
Nephros Announces Results for Quarter Ended March 31, 2021
Net Revenue of $2.7 Million; Highest First Quarter in Company History SOUTH ORANGE, NJ, May…
CytomX Therapeutics Announces First Quarter 2021 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a…
Aprea Therapeutics Reports First Quarter 2021 Financial Results and Provides Update on Business Operations
BOSTON, May 06, 2021 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused…
Translate Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
— Advanced infectious disease vaccine programs with Sanofi Pasteur through initiation of COVID-19 clinical trial…
Vor Reports First Quarter 2021 Financial Results and Provides Company Update
Health Canada clears the CTA for VOR33 clinical trial Vor to present on VOR33 manufacturing…
IGM Biosciences Announces First Quarter 2021 Financial Results and Provides Corporate Update
– Recommended Phase 2 Dose of IGM-2323 Expected in 2021 – – Initial Data from…
ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update
Lead program ORIC-101 on track for two initial Phase 1b data readouts in 2021 Three…
Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
Paltusotine Phase 3 PATHFNDR program in acromegaly initiated in 2Q 2021 Phase 1 data for…
Homology Medicines Reports First Quarter 2021 Financial Results and Recent Highlights
– On Track to Report Initial Phase 2 Data From pheNIX PKU Clinical Trial by…
Viridian Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates
VRDN-001 and VRDN-002 programs for Thyroid Eye Disease (TED) progressing; on track for IND filings…
Ascendis Pharma A/S Announces Presentations for TransCon™ PTH at Upcoming Medical Conferences
COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical…
Recro Reports First Quarter 2021 Financial Results
Revenues of $16.8 Million Represent an Increase of 70% Compared to Q4 2020 Revenue Multiple…
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2021
Reports Net Revenues of $103.0 Million for the Three Months Ended March 31, 2021 RANCHO…
Codexis Reports First Quarter 2021 Financial Results
Total Revenue up 23% and Product Revenue Doubles Year over Year REDWOOD CITY, Calif., May…
Tricida Announces First Quarter 2021 Financial Results
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE)…
T2 Biosystems Announces First Quarter 2021 Financial Results
LEXINGTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
Assembly Biosciences Reports First Quarter 2021 Financial Results and Recent Updates
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…